摘要
通过描述细菌的抗微生物药物耐药(antimicrobial resistance,AMR)的危害和机制,从“同一健康”视角总结国家层面对AMR监管现状,梳理各项政策法规和国家在临床、动物及公共卫生界面建立的细菌耐药性监测网络现状,对现有监测体系存在的数据共享机制缺乏、监测对象和内容不全面、标准化程度低等问题进行剖析,为我国进一步贯通、整合现有AMR监测体系,打破碎片化、局限化、非标准化的监测困境,构建多领域、全链条、数据共享的AMR监测新模式提出参考。
This article analyzes the harmfulness and mechanisms of bacterial antimicrobial resistance(AMR),describes the na-tional supervision of AMR in China from a One Health perspective,summarizes laws,policies and regulations pertaining to AMR and bacterial AMR surveillance networks in clinical,animal and public health interfaces in China,and analyzes the problems in the surveil-lance system,including lack of data sharing mechanisms,incomplete surveillance targets and contents and low standardization level,so as to provide insights into integrating current AMR surveillance systems,breaking the surveillance dilemma of fragmentation,localization and non-standardization,and establishing the novel multi-domain,full-chain and data-sharing AMR surveillance model.
作者
单云峰
秦思
倪云龙
霍翔
SHAN Yun-feng;QIN Si;NI Yun-long;HUO Xiang(Jiangsu Provincial Center for Disease Control and Prevention,Nanjing Jiangsu 210009,China;不详)
出处
《江苏预防医学》
CAS
2024年第2期248-252,共5页
Jiangsu Journal of Preventive Medicine
基金
江苏省卫生健康委科研基金面上项目(M2021078)
江苏省重点研发计划(社会发展)(BE2022837)
江苏省卫生健康委科研基金血地寄项目(x202314)。
关键词
抗微生物药物耐药性
监测网络
同一健康
政策法规
中国
Antimicrobial resistance
Surveillance network
One Health
Policy and regulation
China
